Barrett's metaplasia
暂无分享,去创建一个
J. Jankowski | Ian Perry | Janusz A Jankowski | R. Harrison | Chris Tselepis | C. Tselepis | Rebecca F Harrison | Fran Balkwill | I. Perry | F. Balkwill
[1] D J Ballard,et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. , 1990, Gastroenterology.
[2] R. Cherian,et al. Prospective evaluation of the prevalence of gastric helicobacter pylori infection in patients with GERD, barrett's esophagus, barrett's dysplasia, and barrett's adenocarcinoma , 2000, American Journal of Gastroenterology.
[3] M. Dixon. Patterns of inflammation linked to ulcer disease. , 2000, Bailliere's best practice & research. Clinical gastroenterology.
[4] H. Shinzawa,et al. Endoscopic observation of squamous metaplasia of the stomach: a report of two cases. , 2000, Endoscopy.
[5] H. Friess,et al. Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis , 2000, Gut.
[6] H. Barr,et al. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. , 1998, The American journal of pathology.
[7] R. Poulsom,et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[8] B. Dahms,et al. Barrett's esophagus in three children after antileukemia chemotherapy , 1987, Cancer.
[9] M. Omary,et al. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. , 2000, Gastroenterology.
[10] D. Schaid,et al. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. , 1997, Gastroenterology.
[11] T. Marteau,et al. What parents are told after prenatal diagnosis of a sex chromosome abnormality: interview and questionnaire study , 2001, BMJ : British Medical Journal.
[12] R. Horvat,et al. Mucosa-associated lymphoid tissue (MALT) in Barrett's esophagus: prospective evaluation and association with gastric MALT, MALT lymphoma, and Helicobacter pylori. , 1997, The American journal of gastroenterology.
[13] R. Grosschedl,et al. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. , 1999, Current opinion in cell biology.
[14] G. Tytgat,et al. Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus. , 2000 .
[15] J. Jankowski,et al. Barrett's mucosa: remodelling by the microenvironment , 2000, The Journal of pathology.
[16] Á. Lanas,et al. Superoxide anions produced by inflammatory cells play an important part in the pathogenesis of acid and pepsin induced oesophagitis in rabbits. , 1997, Gut.
[17] Jesper Lagergren,et al. Association between Medications That Relax the Lower Esophageal Sphincter and Risk for Esophageal Adenocarcinoma , 2000, Annals of Internal Medicine.
[18] Carissa A. Sanchez,et al. Evolution of neoplastic cell lineages in Barrett oesophagus , 1999, Nature Genetics.
[19] D. Hopwood,et al. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis. , 1993, The American journal of gastroenterology.
[20] J. Mecklin,et al. Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis , 1999, Gut.
[21] S. Spechler. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. , 1999, Gastroenterology.
[22] M. Czaja,et al. Role of caspases and NF-kappaB signaling in hydrogen peroxide- and superoxide-induced hepatocyte apoptosis. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[23] R. Sampliner,et al. Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk. , 1996, Cancer research.
[24] N. Shepherd,et al. The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. , 1998, The American journal of surgical pathology.
[25] W. Hop,et al. Risk factors for the development of an adenocarcinoma in columnar‐lined (Barrett) esophagus , 1993, Cancer.
[26] R. Donnelly,et al. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. , 1993, Gut.
[27] E. D. Williams,et al. The demonstration of tissue clonality by X‐linked enzyme histochemistry , 1988, The Journal of pathology.
[28] A. Younes,et al. Overexpression of Fas ligand (FasL) during malignant transformation in the large bowel and in Barrett's metaplasia of the esophagus. , 1999, Human pathology.
[29] J. Lagergren,et al. Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia , 1999, Annals of Internal Medicine.
[30] R. Sampliner,et al. Barrett's esophagus: update on screening, surveillance, and treatment. , 1999, Archives of internal medicine.
[31] R. Sampliner,et al. GERD, DGER, or both in Barrett's esophagus? , 1997, The American journal of gastroenterology.
[32] G. Triadafilopoulos. Proton pump inhibitors for Barrett's oesophagus , 2000, Gut.
[33] K. Okita,et al. Metaplastic polyp of the colon develops in response to inflammation , 1999, Journal of gastroenterology and hepatology.
[34] D. Polk,et al. Conversion of TNFα from Antiproliferative to Proliferative Ligand in Mouse Intestinal Epithelial Cells by Regulating Mitogen-Activated Protein Kinase , 1999 .
[35] R. O'Moore,et al. Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus , 1988, The British journal of surgery.
[36] R. Stenling,et al. The esophageal Z-line appearance correlates to the prevalence of intestinal metaplasia. , 2000, Scandinavian journal of gastroenterology.
[37] J. Sung,et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. , 2000, Gastroenterology.
[38] C. McConkey,et al. The rising trend in oesophageal adenocarcinoma and gastric cardia. , 1992, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[39] N. Wright,et al. Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets , 1999, The Journal of pathology.
[40] D. Evans,et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. , 1999, Human molecular genetics.
[41] Carissa A. Sanchez,et al. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. , 2000, Journal of the National Cancer Institute.
[42] D. Kerr,et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. , 1999, The American journal of pathology.
[43] M. Kaminishi,et al. Clonal analysis of isolated intestinal metaplastic glands of stomach using X linked polymorphism , 1998, Gut.
[44] A. Cameron,et al. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. , 1992, Gastroenterology.
[45] P. Kuppen,et al. Secreted and Membrane-Associated Matrix Metalloproteinases of IL-2-Activated NK Cells and Their Inhibitors1 , 2000, The Journal of Immunology.
[46] J. Richter,et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. , 1994, Gastroenterology.
[47] D. Wakelin,et al. Role of T helper 2 cells in intestinal goblet cell hyperplasia in mice infected with Trichinella spiralis. , 1997, Gastroenterology.
[48] M. Carrington,et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.
[49] A. Lindgren,et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.
[50] K. Dabbagh,et al. Agarose plug instillation causes goblet cell metaplasia by activating EGF receptors in rat airways. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[51] A. Poynton,et al. Carcinoma arising in familial Barrett's esophagus. , 1996, The American journal of gastroenterology.
[52] J. Jankowski,et al. Gastro-oesophageal cancer: death at the junction , 2000, BMJ : British Medical Journal.
[53] C. Potten,et al. Gut instincts: thoughts on intestinal epithelial stem cells. , 2000, The Journal of clinical investigation.
[54] G. Kollias,et al. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis , 1999, Nature Medicine.
[55] Vujanić,et al. Diversion colitis in children: an iatrogenic appendix vermiformis? , 2000, Histopathology.
[56] R. Fass,et al. Extension of squamous epithelium into the proximal stomach: a newly recognized mucosal abnormality. , 2000, Endoscopy.
[57] C. Price,et al. Recurrent mis-splicing of fibrillin exon 32 in two patients with neonatal Marfan syndrome. , 1995, Human molecular genetics.
[58] J. Goldblum,et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. , 1998, Gastroenterology.
[59] B. Vogelstein,et al. Clonal origin of bladder cancer. , 1992, The New England journal of medicine.
[60] P. Sodhani,et al. Columnar and metaplastic cells in vault smears: cytologic and colposcopic study , 1999, Cytopathology : official journal of the British Society for Clinical Cytology.
[61] J. Cameron,et al. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. , 1985, American journal of surgery.
[62] Ian Tomlinson,et al. Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog , 1999, Nature medicine.
[63] R. Fitzgerald,et al. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. , 1999, Gastroenterology.
[64] D. Skinner,et al. Barrett's Esophagus: Comparison of Benign and Malignant Cases , 1983, Annals of surgery.